The Expression of Apolipoprotein D in Hepatocellular Carcinoma
Korean Journal of Pathology
; : 187-190, 2010.
Article
em En
| WPRIM
| ID: wpr-48172
Biblioteca responsável:
WPRO
ABSTRACT
BACKGROUND:
Apolipoprotein D (Apo D) has recently been identified as a novel tumor suppressor gene. Apo D may have a profound effect on the carcinogenesis and progression of hepatocellular carcinoma. This study was designed to evaluate the expression of Apo D in hepatocellular carcinoma and to investigate the relationship between the expression of Apo D and the clinicopathological characteristics and the patients' survival.METHODS:
An immunohistochemical study was performed on the tumors and tissues from 43 hepatocellular carcinoma (HCC) patients with controls to determine the expression of Apo D protein.RESULTS:
Our data showed that a higher expression of Apo D was seen in 10 of 43 cases (23.3%), while a lower and no expression of Apo D was observed in 28 of 43 cases (65.1%) and 5 of 43 cases (11.6%), respectively. A reduced expression of Apo D was correlated with the tumor stage (p = 0.037) and tumor size (p = 0.017). However, the patients' 5-year survival was not associated with the expression of Apo D (p = 0.903).CONCLUSIONS:
The results suggest that a reduced Apo D protein expression may play an important role in HCC progression as associated with the tumor stage and size, but it does not affect the survival of HCC patients.Palavras-chave
Texto completo:
1
Base de dados:
WPRIM
Assunto principal:
Apolipoproteínas
/
Genes Supressores de Tumor
/
Carcinoma Hepatocelular
/
Progressão da Doença
/
Apolipoproteínas D
Limite:
Humans
Idioma:
En
Revista:
Korean Journal of Pathology
Ano de publicação:
2010
Tipo de documento:
Article